A recent meta-analysis including 4770 cases and 5701 controls exploring the association between GSTO polymorphisms and cancer risk showed no significant association between the GSTO1 polymorphism and cancer susceptibility whereas the “GG” genotype of the GSTO2 polymorphism was observed to increase the risk of overall cancer and breast cancer (45). The gene discussed is GSTO1; the disease is breast cancer.